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Intracellular pathogens modulate host cell function
to promote their survival. However, in vitro infection
studies do not account for the impact of host-derived
inflammatory signals. Examining the response of
liver-resident macrophages (Kupffer cells) in mice
infected with the parasite Leishmania donovani, we
identified a transcriptomic network operating in
uninfected Kupffer cells exposed to inflammation
but absent from Kupffer cells from the same animal
that contained intracellular Leishmania. To test the
hypothesis that regulated expression of genes within
this transcriptomic network might impact parasite
survival, we pharmacologically perturbed the activity
of retinoid X receptor alpha (RXRa), a key hub within
this network, and showed that this intervention
enhanced the innate resistance of Kupffer cells to
Leishmania infection. Our results illustrate a broadly
applicable strategy for understanding the host
response to infection in vivo and identify Rxra as
the hub of a gene network controlling antileishmanial
resistance.
INTRODUCTION
Intracellular pathogens have evolved over many millions of years
to coexist in the faceof awide array of host defensemechanisms.
In vitro studies of the host-pathogen interaction exclude the in-
flammatory milieu, but a major challenge in studying the host
response in vivo is dissecting pathogen-specific responses
from the general inflammatory or common host response (Jenner
andYoung, 2005) that occurs as a result of tissue insult during the
infectious process. This latter response is in part driven by activa-
tion of components of the complement cascade (Ricklin et al.,
2010), the coagulation pathway (Oikonomopoulou et al., 2012),
and the acute phase response (Suffredini et al., 1999), which all
come into play within minutes of infection, and is compounded
by rapid changes to the inflammatory cytokine and chemokine
environment (Oghumu et al., 2010; Sadik and Luster, 2012;Cell Host & MSoehnlein and Lindbom, 2010). Each of these stimuli may have
profound effects on phagocyte function (Galvan et al., 2012;
Hoffmann et al., 2010) and reflect, in the broader sense, the
normal and/or essential response of phagocytes to inflammatory
insult. Hence, responses that directly reflect intracellular
infection are difficult to distinguish from dominant inflammatory
signatures by conventional experimental approaches. We hypo-
thesized that it might be possible to use the transcriptomic
response of uninfected cells exposed to inflammation as a mea-
sure of the baseline or normal in vivo response to insult. Following
this argument, transcriptomic networks specifically observed in
infected cells, but not in neighboring uninfected cells, would
represent cell-intrinsic pathogen-induced changes. In contrast,
transcriptomic networks restricted to uninfected cells would
serve to identify responses potentially beneficial to the host,
the lack of which (in infected cells) might favor pathogen survival.
We tested the above hypothesis in a tractable experimental
model of Leishmania infection, a pathogen associated with a
significant global health burden (Alvar et al., 2012). Leishmania
infect a variety of myeloid cells (including tissue-resident macro-
phages, inflammatory monocytes, dendritic cells [DCs], and
neutrophils), but in models of experimental visceral leishmani-
asis, Leishmania donovani amastigotes have a predilection for
resident tissue macrophages, including Kupffer cells (KCs), the
resident tissue macrophage lining the hepatic sinusoids (Beattie
et al., 2010; Murray, 2001).
In this study, we discovered that expression of an Rxra-cen-
tered transcriptomic pathway, which is downregulated in KC in
response to inflammation, is aberrantly maintained in infected
cells. Pharmacological manipulation of RXRa activity perturbed
the transcriptomic network of infected KCs, leading to enhanced
leishmanicidal activity. This study demonstrates that aberrant
expression of the Rxra-centered transcriptional pathway in
Leishmania-infected KCs favors parasite survival and validates
the use of cells exposed to inflammation as a means to discover
pathogen-regulated transcriptomic pathways in vivo.
RESULTS
An In VivoAssay for theAnalysis of KupfferCell Behavior
In the livers of uninfected (LysM-Cre 3 mT/mG)F1 mice, KCs
were obvious from their large size, expression of membraneicrobe 14, 357–368, September 11, 2013 ª2013 Elsevier Inc. 357
Figure 1. An In Vivo Assay for the Analysis of Kupffer Cell Behavior
(A) Intravital analysis of KC (green) in liver sinusoids (red) in naive (LysM-Cre 3 mT/mG)F1 mice. Arrows indicate moving monocytes and/or neutrophils. Arrow
heads show stationary KCs. See also Movie S1.
(B–E) Measurement of the parameters of cell volume (B), surface area (C), shape factor (D), and velocity (E) for single KCs in 3 dimensions over time. Data
represent 42 KCs from 2 mice.
(F–I) Shown are the average volume (F), surface area (G), shape factor (H), and velocity (I) over time for KC, LSEC, and monocytes and/or neutrophils. Data are
represented as mean ± SEM. Data represent 35 KCs, 8 LSECs, and 19 monocytes and/or neutrophils from 2 mice.
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Macrophage Response to Leishmania In VivoGFP, and their continued and intimate contact with liver sinusoi-
dal endothelial cells, as has been previously described (Lee
et al., 2010; Naito et al., 2004). Four-dimensional (4D) intravital
two-photon imaging further allowed the finemembrane structure
and lamellipodia dynamics of steady-state KCs to be observed
in exceptional detail (Figure 1A; Movie S1). The continued exten-
sion and retraction of KC lamellipodia manifested itself as small
fluctuations of cellular volume (Figure 1B) and surface area over
time (Figure 1C). In contrast, monocytes and/or neutrophils were
identified as moving rapidly through the sinusoidal spaces,
whereas liver sinusoidal endothelial cells (LSECs) lined the sinu-
soidal lumen (Figures 1F and 1G). Shape factor, a quantitative
measure of how close a cell is to a perfect sphere (shape fac-
tor = 1), showed small fluctuations over time for KCs (Figure 1D)
but was always lower than that for either LSECs or monocytes
and/or neutrophils (Figure 1H). The effects of KCmembrane fluc-
tuation can also be represented by a velocity, which was calcu-
lated by measuring the movement around the centroid point of
the cell in three dimensions. KC velocity showed significant fluc-
tuations over time (Figure 1E). Thus, although KCs do not actively
migrate along the sinusoids, velocity as measured here provides358 Cell Host & Microbe 14, 357–368, September 11, 2013 ª2013 Elan indication of the extent of membrane activity. In contrast,
nonmotile LSECs have an even lower velocity (limitedmembrane
activity). Many of the monocytes and/or neutrophils that were
examined actively migrated along the sinusoids within the time
frame of observation, and their velocity was not surprisingly
high (Figure 1I).
Phagocytosis of L. donovani Amastigotes Results in
Rapid Activation of Both Infected and Uninfected KCs
As the early response of KCs to infection with L. donovani amas-
tigotes in vivo is largely uncharacterized, we examined KC
behavior before and after infection in live mice. We injected
(LysM-Cre 3 mT/mG)F1 mice with transgenic Td-Tomato-
expressing L. donovani amastigotes (Beattie et al., 2010) at a
dose that resulted in approximately 20% of KCs becoming in-
fected over a 2 hr time period (a time by which most parasites
have been cleared from the blood by KCs and other tissue
phagocytes; Figures 2A and 2B; Gorak et al., 1998). The binding
of amastigotes to the KCmembrane (Figure 2A) was followed by
complete phagocytosis within 20 s (Movie S2). Neither injec-
tion of live, nor of heat-killed, amastigotes resulted in detectablesevier Inc.
Figure 2. Leishmania Injection Causes Rapid Activation of Both Infected and Uninfected KCs
(A) Real-time injection of L. donovani amastigotes (red, white arrows) and phagocytosis by KC (green). See also Movie S2.
(B–F) Intravital imaging for 2 hr postinjection (B) and analysis of both infected (white arrows) and uninfected KCs for the parameters of volume (C), surface area (D),
shape factor (E), and velocity (F). Infected KCs (red), inflamed KCs (black). Data are represented as mean ± SEM. Data represent 34 KC from 2 mice for RPMI, 29
infected KCs, and 36 uninfected KCs from 3 mice for live amastigotes, and 15 infected and 33 uninfected KC from 3 mice for dead amastigotes. Data were
analyzed using a one-way ANOVA; **p < 0.01, ***p < 0.001.
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irrespective of whether or not the KCs contained visible amasti-
gotes. In contrast, injection of live, but not dead, amastigotes
induced a rapid increase in the average shape factor that was
significant for KCs that contained live parasites and showed a
trend in this direction for KCs that did not contain amastigotes
(Figure 2E). When velocity was measured as an indicator of
membrane activity (Figure 2F), a significant decrease was
observed in both infected and uninfected KCs following injection
of live amastigotes, suggesting that both populations of cells
were responding to the inoculated parasites through rapid acti-
vation. Such activation was not observed following injection of
dead amastigotes (Figure 2F). Collectively, these data were
indicative of a cellular response to active infection, rather than
a response merely to nonspecific debris that may be present
within the amastigote preparations. The observation that unin-
fected KCs in the immediate vicinity of infected cells also re-
sponded to the infection by loss of membrane activity (Figure 2F)
suggested that the above changes in KC behavior were the result
of either signals provided from infected KCs and operating
rapidly in trans or from the activation of serum-derivedmediatorsCell Host & Mof inflammation, rather than being a direct consequence of
intracellular parasitism per se. In either case, the capacity to acti-
vate this response was absent from heat-killed amastigote
preparations.
Analysis and Separation of Kupffer Cells Shows
Heterogeneity in the Infected and Uninfected
Populations
As we wished to examine the transcriptional events that accom-
panied the observed change in KC behavior, we developed a
method to identify and isolate KCs based on whether they con-
tained parasites (herein termed infected) or not (herein termed in-
flamed). Flow cytometry analysis of hepatic mononuclear cell
preparations with gating on forward and side scatter (Figure 3A),
complement receptor of the immunologlobulin superfamily
(CRIg) (Helmy et al., 2006), and Gr-1 (Figure 3B) demonstrated
that both infected and inflamed populations of KCs could be
observed and discriminated by the presence of fluorescent
amastigotes (Figure 3C). Both infected and inflamed KCs
showed heterogeneous expression of CD11b but relatively uni-
form expression of F4/80 (Figure 3D). Backgating on the infectedicrobe 14, 357–368, September 11, 2013 ª2013 Elsevier Inc. 359
Figure 3. Analysis and Isolation of Infected and Inflamed KCs
(A–C) C57BL/6 mice were infected with PKH26-labeled Leishmania donovani amastigotes, and the KCs were examined 12 hr later. KCs were gated on FSC and
SSC (A), CRIg and GR-1 expression (B), and the presence of parasites (C).
(D and E) Infected and uninfected KCs showed similar expression profiles for CD11b and F4/80 (D) and even distribution among the CRIg+ GR-1lo and CRIg+
GR-1hi populations (E).
(F–I) Labeling of liver sections with F4/80 (F), CRIg (G), and GR-1 (H), or overlay of the three with DAPI (blue) (I), shows variable expression of GR-1 on KCs with a
CRIg F4/80 GR-1+ neutrophil noted (white arrow).
(J–L) KCs were sorted 2 hr and 12 hr postinjection of tdTomato-L. donovani amastigotes, based on FSC and SSC (J), expression of CRIg and GR-1 (K), and
expression of F4/80 (L).
(M–O) The sorted KCs (M) were then further sorted into uninfected (N) and infected (O) populations.
(P and Q) Giemsa-stained cytospins confirmed macrophage morphology and absence (P) or presence (Q) of amastigotes (arrows). See also Table S1.
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CRIg+ Gr-1High cells and CRIg+ Gr-1int cells (Figure 3E). To
confirm that a proportion of KCs express Gr-1 in situ, we labeled
liver sections with F4/80, CRIg, and Gr-1 (Figures 3F–3I) and360 Cell Host & Microbe 14, 357–368, September 11, 2013 ª2013 Elobserved variable expression of Gr-1 on KCs, in addition to
GR-1+ neutrophils that did not express CRIg or F4/80 and
were readily identifiable from their irregular-shaped nuclei (Fig-
ures 3H and 3I).sevier Inc.
Figure 4. Comparative Subtraction Demon-
strates Aberrant Expression of a Lipid
Metabolism Pathway Centered around
Rxra in Infected KCs
(A) The method used for the separation and anal-
ysis of genes regulated in infected KCs, in in-
flamed KCs, or in both.
(B) The number of genes in each list at 12 hr
postinfection.
(C) The lipid metabolism, small-molecule
biochemistry, and molecular transport pathway.
Green symbols denote downregulated genes, red
symbols denote upregulated genes. Arrows with
unbroken lines indicate a direct interaction be-
tween two molecules, with the mode of action in
the direction of the arrow; arrows with broken lines
denote an indirect interaction. See also Figure S1.
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to isolate KCs and separate them into either infected or unin-
fected cell populations. We identified KCs from infected mice
at 2 hr and 12 hr postinfection (p.i.), as described above, based
on forward and side scatter (size and granularity) (Figure 3J) and
expression of CRIg, GR-1 (Figure 3K), and F4/80 (Figure 3L) and
then further sorted these based onwhether or not they contained
parasites (Figures 3M–3O). Cytospins of the sorted populations
demonstrated that the cells had macrophage-like morphology,
that neutrophils were not included in the analysis, and the pres-
ence of amastigotes within the infected population (Figure 3Q),
but not in the inflamed population (Figure 3P). KCs were also iso-
lated from sham-infected mice to serve as a control population
that exhibited steady-state activity.
Transcriptomic Profiling of Inflamed and Infected KCs
Demonstrates Both Common and Distinct Pathways
To determine whether there were underlying transcriptional
events that differed between KCs infected with amastigotes in
an inflammatory setting and those induced in KCs exposed to in-
flammatory stimuli alone, transcriptomic profiles for each popu-
lation, in addition to KCs from sham-infected controls, were
generated by microarray analysis. Instead of performing a direct
comparison of the differences in gene expression between the
infected and inflamed KCs, we generated a list of genes differen-
tially expressed between infected KCs and sham-infected KCs
(using a cutoff of >3-fold difference). This approach eliminated
the possibility that any of the regulated genes were induced or
suppressed due to the isolation procedure, as the sham-infected
KCs were subjected to the same digestion and sort process. The
same analysis was then performed for the inflamed KCs. As a
result of this analysis, we therefore generated two gene lists (in-
fected and inflamed KCs) for 2 hr p.i. and two gene lists for 12 hr
p.i. At 2 hr p.i., the expression of 1,188 genes (909 up and 279
down) was differentially regulated between sham-treated and in-
fected KCs, whereas only 353 genes (327 up and 26 down) wereCell Host & Microbe 14, 357–368, Sedifferentially regulated between sham-
treated and inflamed KCs. By 12 hr
p.i., the number of genes showing
changes in expression was substantially
increased (2,135 between sham-treatedand infected KCs, of which 1,337 had increased, and 798 had
decreased, expression). STRING analysis of these genes
showed that although there were some interactions between
these genes, there were a large number of genes that were
outside of the central network (Figure S1). Although substantially
fewer genes (1,288) were differentially expressed at amessenger
RNA (mRNA) level between the sham-treated and inflamed KCs
overall (713 upregulated and 575 downregulated), STRING anal-
ysis for these genes showed a higher degree of connectivity
between the genes within this list and a substantial network
connection that did not appear to be present in the infected cells
(Figure S1). The top 20 genes (based on fold change compared
to sham-infected KCs for each comparison, or according to rela-
tive expression) are provided in Table S1. We interpret these
data as indicating that there are genes that are normally regu-
lated as part of the inflammatory response that are not regulated
in infected cells.
Rxra Forms the Hub of a Transcriptomic Network that Is
Regulated in Inflamed, but Not Infected, KCs
To determine the identity of genes and gene pathways that were
common between the infected and inflamed cells, and those that
were unique to either population, we performed a subtractive
analysis of the gene lists (Figure 4A). From this analysis, we could
readily identify genes that were either commonly regulated in
both infected and inflamed cells or uniquely regulated in either in-
fected or inflamed KCs at both 2 hr and 12 hr p.i. (Figures 4A, 4B,
and S1C). For all genes identified as being selectively or
commonly expressed in infected KCs and inflamed KCs, we
have provided the top 20 genes ranked by expression level
(Table S2). The gene lists were then subjected to pathway and
gene ontology (GO) analysis (see Experimental Procedures for
detail). A total of 1,088 genes were uniquely regulated in their
expression at 12 hr p.i. in infected cells. Genes that showed
differentially regulated expression in both infected and inflamed
cells were enriched for GO terms suggestive of responsivenessptember 11, 2013 ª2013 Elsevier Inc. 361
Table 1. Fold Change and Expression Values for Genes in the
Lipid Metabolism and Small-Molecule Biochemistry Pathway, as
Shown in Figure 4C
Gene
Symbol
Fold Change
Control versus
Inflamed
Fold Change
Control versus
Infected
12 hr
Control
12 hr
Inflamed
12 hr
Infected
Omd 4.579 2.848 0.76 1.435 0.75
Ptgis 4.028 2.937 0.577 1.433 0.977
Pltp 3.998 2.728 0.389 1.61 1.058
Scarb1 3.819 2.907 1.467 0.466 0.072
Cepba 3.751 2.479 0.864 1.043 0.446
Rxra 3.56 2.565 0.545 1.286 0.814
Vamp4 3.164 2.487 0.569 1.092 0.745
Acot1 3.09 1.512 0.128 1.756 0.724
Fabp7 3.085 1.74 0.087 1.538 0.712
Scd1 3.031 2.183 0.399 1.201 0.728
Kcnn4 3.216 2.986 0.617 1.069 0.962
Stc1 3.437 2.919 0.857 0.924 0.689
Ccnd2 3.438 2.514 0.491 1.291 0.84
Fgf15 3.573 1.846 1.785 0.052 0.901
Il23a 3.629 2.254 1.027 0.832 0.145
Cebpe 3.714 2.821 1.407 0.486 0.089
Slcoa5 3.786 2.448 0.235 1.686 1.057
Nlrp12 3.842 1.901 1.838 0.104 0.911
Tro 4.198 2.356 0.694 1.376 0.543
Mt2a 4.246 2.455 1.307 0.779 0.011
Hp 4.505 2.837 1.944 0.227 0.44
Table shows expression values (log2) for control, inflamed and infected
cells, and fold change (positive values, upregulated; negative values,
downregulated) in gene expression for inflamed and infected cells versus
control cells. See also Table S2.
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response and cytokine-cytokine receptor interaction and che-
mokine activity.
Significantly, we identified 241 genes that were differentially
regulated in their expression in inflamed cells, but not in cells
that contained intracellular amastigotes, in spite of exposure of
these cells to the same inflammatory insult. Ingenuity pathway
analysis (IPA) was then used to identify genes that fell within
IPA-generated pathways at a higher frequency than would nor-
mally be expected to occur for a randomly selected set of genes.
This analysis identified 8 interacting networks within the inflamed
gene list, in which genes involved in cell-to-cell signaling and the
inflammatory response (IPA network score of 38), cell death (IPA
network score of 37), antigen presentation (IPA network score of
35), cancer (IPA network score of 26), immune cell trafficking and
cell cycle (IPA network score of 23), and cell morphology and
cellular compromise (IPA network score of 10) were all overrep-
resented. The network that showed the highest level of gene
enrichment was that of the lipid metabolism and small-molecule
biochemistry pathway (Figure 4C), which had an IPA network
score of 40. The fold change and the expression values for this
pathway are shown in Table 1.
As the above networks were not regulated in infected cells,
we hypothesized that they might represent genes and gene362 Cell Host & Microbe 14, 357–368, September 11, 2013 ª2013 Elpathways for which homeostasis was favorable to parasite sur-
vival and, inter alia, that they represented genes potentially
associated with antimicrobial defense regulated by inflamma-
tion. To test this hypothesis, we selected the most substantially
represented network for further proof-of-concept studies
(Figure 4C).
IPA identified that, 11% (27/241 genes) of genes selectively
regulated in their expression in inflamed KCs were found within
the lipid metabolism and small-molecule biochemistry pathway
(Figure 4C), which had retinoid X receptor a (Rxra) as a key hub
(with Rxra itself being downregulated 3.5-fold in inflamed cells).
We then sought to confirm the level of mRNA accumulation in
infected and inflamed KCs in independent samples by quantita-
tive real-time PCR (Figure 5). Although Rxra mRNA expression
was not significantly different in infected and inflamed cells (Fig-
ure 5B), other genes within this network were validated as being
differentially expressed between infected and inflamed cells,
including Cebpa (Figure 5C), Vamp4 (Figure 5D), LXRa/Nr1h3
(Figure 5F), and LXRb/Nr1h2 (Figure 5G).
Pharmacological Modulation of RXRa Activity In Vivo
Inhibits the Upregulation of the Rxra Network-
Associated Genes in Infected KCs
As infection with Leishmania resulted in maintenance or upregu-
lation of expression of genes within the Rxra-associated gene
network, we reasoned that if this was associated with parasite
survival, then forced down modulation of RXRa activity might
sufficiently perturb the entire Rxra-related gene network within
infected cells to generate an enhanced antimicrobial effect.
We therefore tested this approach by targeted pharmacological
intervention, using a small-molecule antagonist HX531, specific
for RXRa (Ebisawa et al., 1999; Yamauchi et al., 2001). To first
establish that HX531 treatment had a direct effect on the gene
network in infected KCs, we treated mice with HX531 or saline,
infected the mice with L.donovani, and isolated infected or in-
flamed KCs to examine gene expression by quantitative real-
time PCR (Figure 5A). HX531 treatment had no significant effect
on the expression of Rxra at an mRNA level (Figure 5B), but
treatment resulted in a significant modulation of the expression
of a number of network-associated genes, including Cebpa (Fig-
ure 5C), Vamp4 (Figure 5D), Vdr (Figure 5E), LXRb (but not LXRa)
(Figures 5F and 5G), and Rara (Figure 5H). Importantly, this
effect was restricted to infected KCs. Peroxisome proliferator-
activated receptor g (Pparg) was not regulated in infected cells
(Figure 5I) and showed no change in expression following
HX531 treatment. We also examined the effect of HX531 treat-
ment on a number of RXR-related genes that were not repre-
sented within the identified network (Figure 4C), including
Abca1 (Figure 5J), Abcg1 (Figure 5K), ApoE (Figure 5L),
Cyp27a1 (Figure 5M), and Cyp27b1 (Figure 5N). HX531 treat-
ment had no measurable effect on the expression of these
genes in KCs, with the exception of Abca1, where treatment
appeared to block upregulation in uninfected cells (Figure 5J).
HX531 treatment blocked the upregulation of IL-1b in infected
KCs (Figure 5O) but had no effect on inducible nitric oxide syn-
thase (iNOS) mRNA levels in infected or inflamed KCs
(Figure 5P).
To confirm that genes within this network were not subject to
regulation merely by phagocytosis, we performed RT-PCR for asevier Inc.
Figure 5. Inhibition of RXRa Modulates Gene Expression in Infected and Inflamed KCs
(A) Mice were treated with HX531 or saline and then infected.
(B–P) After 12 hr, infected (red) and inflamed (black) KCs were isolated to determine the relative mRNA accumulation of Rxra (B), Cebpa (C), Vamp4 (D), Vdr (E),
LXRa (F), LXRb (G), Rara (H), Pparg (I), Abca1 (J), Abcg1 (K), ApoE (L), Cyp27a1 (M), Cyp27b1 (N), IL-1b (O), and iNos (P) expressed as the relative expression
compared to KC isolated from sham-infected control mice (relative expression of 1). Individual symbols represent cells isolated from pools of four mice, sorted
independently. Data are represented as mean ± SEM. Data were analyzed using one-way ANOVA with Tukey’s post test. *p < 0.05, **p < 0.01, ***p < 0.001. See
also Figure S2.
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jected with latex beads. As shown in Figure S2, uptake of latex
did not affect mRNA levels for Rxra (Figure S2A), LXRb (Fig-
ure S2B), Cebpa (Figure S2C), or Vamp4 (Figure S2D), relative
to KC isolated from control-injected mice.Cell Host & MPharmacological Modulation of RXRa Activity Reduces
Leishmania Survival in KC
To determine the effect that the perturbation of the RXRa
pathway would have on infection, and hence to examine the po-
tential of the expression profiling approach that we have used foricrobe 14, 357–368, September 11, 2013 ª2013 Elsevier Inc. 363
Figure 6. Therapeutic Targeting of RXRa Impairs L. donovani Survival within Macrophages
(A) Mice were pretreated with HX531, LG268, GW3965, or saline and infected 2–6 hr later. Parasite burdens were determined after 2 hr and 96 hr.
(B and C) Number of parasites present in the spleen (B) and liver (C) 96 hr after infection, as measured by flow cytometry.
(D and E) The fold increase in parasite burden relative to the 2 hr time point in the spleen (D) and liver (E).
(F) The percentage of KCs infected at 96 hr determined by fluorescence microscopy.
(G) The percentage of KCs infected at 96 hr relative to the percent infected at 2 hr. Individual symbols represent individual mice, and data are representative
of three independent experiments for HX531 treatment and control groups and 1 experiment for LG268 and GW3965 treatments. Data are represented as
mean ± SEM.
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mice with HX351 prior to and for 4 days following infection
with Td-tomato L. donovani amastigotes (Figure 6A). Using a
flow cytometric approach to quantify the number of parasites
in the tissues, we first assessed splenic and hepatic parasite
burden at 2 hr p.i., when there was no difference in the presence
or absence of treatment, and at 96 hr p.i. (Figures 6B and 6C).
HX531 treatment significantly reduced the number of parasites
present in both the liver and the spleen at 4 days postinfection
relative to the saline-treated control animals. To examine
whether perturbation in this pathway could also be achieved
by stimulating, rather than inhibiting, RXRa, we treated mice
with LG268 (an RXR agonist). LG268 also reduced the
number of parasites present in the spleen but not the liver. To
determine whether RXRa perturbation could be operating
through effects on LXR, we treated mice with GW3965 (an LXR
agonist). GW9395 treatment had no effect on parasite burden
in either tissue (Figures 6B and 6C), suggesting that LXR is not
involved in control of parasite load mediated through the RXRa
network. In order to examine if the therapeutic effect observed
reflected leishmanistatic or leishmanicidal activity, we also
calculated the fold change in parasite numbers in the 2 organs
at 4 days p.i. relative to the number of parasites present at 2 hr
p.i. (Figures 6D and 6E). In spleens of untreated mice, parasite
numbers increased over a 96 hr period, and this growth was in-
hibited after drug treatment. In contrast, in liver, parasite
numbers did not increase significantly over 96 hr in nontreated
mice and were reduced to below the level seen at 2 hr p.i. in
drug-treated mice, suggestive of leishmanicidal activity (Fig-
ure 6E). To confirm this observation, we used a histological
approach in the liver and further showed that the percentage364 Cell Host & Microbe 14, 357–368, September 11, 2013 ª2013 Elof infected KCs was significantly reduced in the LG268-treated
animals and showed a trend in this direction in HX531-treated
mice but not in GW3965-treated mice (Figures 6F and 6G).
Although not significant in the single experiment shown in Fig-
ure 6, replicate experiments with mice treated with HX531
confirmed that this drug enhanced the leishmanicidal activity
of KCs (p = 0.0028; n = 11 mice for saline controls and 8 mice
for HX531 treatment). In conclusion, these data indicate that
pharmacological manipulation of RXRa function was sufficient
to perturb the gene network that we identified as being aber-
rantly expressed in infected KCs. Furthermore, it was unlikely
that the effects of HX531 or LG268 were due to direct effects
on LXR, as stimulation of LXR had no measurable biological
effect.
DISCUSSION
We have examined the early in vivo response of liver macro-
phages to infection with Leishmania, independently studying
the activation of infected and uninfected cells exposed to inflam-
matory signals within the infected tissue microenvironment. Our
approach provides a number of unique insights into the tran-
scriptomic response induced by L. donovani infection in vivo
and provides proof of concept that the use of cells exposed to
inflammation is a powerful method for the discovery of path-
ogen-regulated gene pathways.
First, the isolation of KC from infected mice revealed a tran-
scriptional response in infected KCs that is somewhat distinct
from that observed by others using different types of mononu-
clear host cells (including bone marrow-derived macrophages,
monocytes, and DCs). It remains to be determined whethersevier Inc.
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the analysis being performed on cells infected in vitro versus
in vivo. In most previous in vitro experiments, the possible influ-
ence of uninfected cells on gene expression profile, e.g., by dilu-
tion of the signal associated with infected cells, was not taken
into account (Buates and Matlashewski, 2001; Chaussabel
et al., 2003; Osorio y Forte´a et al., 2009; Rodriguez et al.,
2004). In one series of studies, DCs infected in vitro with
L. amazonensis were sorted to allow microarrays to be conduct-
ed only on infected cells (Giraud et al., 2012; Lecoeur et al.,
2010). While these studies revealed unique signatures not
evident from bulk population analysis, data were not provided
to show whether the uninfected DC within the culture system
had also made bystander responses (e.g., mediated by cytokine
release from infected DCs in culture). Furthermore, the transcrip-
tomic signatures generated by microarray in this and indeed
most other studies (including those cited above) have not been
validated fully at the protein level.
Second, our data demonstrate significant quantitative and
qualitative differences in transcriptomic responses compared
to previous in vitro gene expression studies. In vitro experiments
have usually been interpreted as indicating that visceralizing
species of Leishmania result in a relatively silent infection ofmac-
rophages (Zhang et al., 2010), significant suppression of gene
expression (Buates and Matlashewski, 2001), or a signature
distinct from that associated with interferon (IFN)-g activation
(Rodriguez et al., 2004). The tendency of L. donovani to induce
a weak inflammatory response in vitro may be species specific,
with L. donovani metacyclics inducing lower fold changes in in-
flammatory gene expression compared to L. major metacyclics
in one study (Chaussabel et al., 2003). Alternatively, there may
be life cycle stage-specific determinants of gene expression,
as shown for L. mexicana (Aebischer et al., 2005). In an additional
study, L. amazonensis amastigotes were also shown to induce
significant gene expression changes in vitro, including changes
to the sterol biosynthesis pathway (Osorio y Forte´a et al.,
2009). Importantly, the impact of L. chagasi on host macrophage
responsewas significantlymodulated by the addition of T cells to
the culture in vitro (Ettinger and Wilson, 2008), suggesting that
factors external to the infected macrophage impact the
response of the infected cell. Our data support and extend these
observations by adding the full in vivo complexity of themicroen-
vironment created in the infected liver.
Third, we show that uninfected KCs also undergo significant
biological and gene transcriptional changes associated with
the inoculation into mice of live L. donovani amastigotes. The
activation of uninfected KCs at early time points, with further
downstream transcriptional consequences seen at 12 hr, sug-
gests that soluble mediators or signals operating in trans facili-
tate global activation of macrophages within the infected tissue.
Although this activation shows both qualitative and quantitative
differences between infected and inflamed KCs, many of the
genes that have been associated with cell-autonomous defense
against intracellular protozoa stimulated by interferons (Mac-
Micking, 2012) are induced to similar levels in infected and unin-
fected KCs at 12 hr postinfection. This would place such genes in
the category of commonly-regulated geneswithin the framework
of our analysis. Such genes include the guanylate-binding pro-
teinsGbp2 andGbp5, indoleamine 2,3-dioxygenase 1 (Ido1), im-Cell Host & Mmunity-related GTPase family M members 1 and 2 (Irgm1 and
Irgm2), and immunoresponsive gene 1 (Irg1). These data are
somewhat intuitive, given that IFN is a soluble mediator, capable
of trans-activating neighboring cells.
Collectively, our comparative analysis of the gene expression
profiles of infected and inflamed KCs taken from the livers of
infected mice suggests that a degree of caution should be exer-
cised when interpreting whether genes observed to alter their
expression in response to infection truly represent autonomously
regulated genes associated with the presence of intracellular
pathogens.
Fourth, we have identified and validated the importance of a
gene network centered around Rxra that is associated with the
survival of amastigotes within the liver of L. donovani-
infected mice. Within this Rxra network, we identified a predom-
inance of genes associated with lipid metabolism. Although lipid
metabolism centered around RXRa has not previously been
implicated in L. donovani pathogenesis in mice, other studies
have observed changes in lipid metabolism genes associated
with Leishmania infection. For example, changes in components
of the sterol biosynthesis pathway were induced bymacrophage
infection with L. amazonensis (Osorio y Forte´a et al., 2009). Pre-
vious studies have characterized a role for two heterodimeric
partners of RXR in the control of Leishmania major infection,
the vitamin D receptor (VDR) (Ehrchen et al., 2007; Whitcomb
et al., 2012) and the liver X receptor (LXR) (Bruhn et al., 2010),
with deficiency in either receptor resulting in enhanced resis-
tance to infection. In addition, upregulation of VDR was previ-
ously reported following in vitro infection of macrophages with
L. chagasi (Rodriguez et al., 2004) as well as L. donovani and
L. major (Chaussabel et al., 2003), suggesting that VDR is an
important component of the host response to Leishmania infec-
tion. We believe that by targeting RXRa as the hub of the identi-
fied network, we have successfully perturbed an entire gene
network that controls L. donovani survival in KCs. Perturbation
of RXR in either direction via activation with the agonist LG268
or suppression with the antagonist HX531 had similar effects
on the growth of L. donovani in vivo. This suggests that a delicate
balance of expression exists across the RXR gene network. The
mechanism by which this network controls parasite survival is
currently subject to further investigation. However, we speculate
that the gene network may regulate the usage of lipids and
cholesterol by the parasite while it is present in the phagolyso-
some of the host cell (McConville and Naderer, 2011). Alterna-
tively, macrophage sensing of Leishmania-derived lipids may
be having profound effects on the nature of the innate immune
response that is initiated (Nagy et al., 2012).
Finally, and of broader significance, we have described an
approach to study host-pathogen interactions, which is capable
of revealing important host response pathways that would be
invisible in studies of the interaction between macrophages
and pathogens in vitro. Importantly, we show that manipulation
of such pathways in vivo can impact parasite survival, reducing
parasite load at early stages after liver infection. Targeting of
nuclear receptors for therapy is a burgeoning field of medicine,
with RXR therapeutics showing efficacy in clinical settings of
cutaneous T cell lymphoma (Duvic et al., 2001; Khuri et al.,
2001) and a preclinical model of Alzheimer’s disease (Cramer
et al., 2012). RXR antagonists, including HX531, have also shownicrobe 14, 357–368, September 11, 2013 ª2013 Elsevier Inc. 365
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diabetes (Yamauchi et al., 2001). In this respect, while it is
tempting to suggest that our findingsmay also set the foundation
for the use of RXR-mediated therapies for leishmaniasis, detailed
investigations into the mechanism of parasite growth arrest and/
or killing are now required.
EXPERIMENTAL PROCEDURES
Mice and Infection
C57BL/6 mice were obtained from Charles River (UK). mT/mG (Muzumdar
et al., 2007) and LysMcre (Clausen et al., 1999) mice have been previously
described. Mice were bred and housed under specific pathogen-free condi-
tions and used at 6–12 weeks of age. The Ethiopian strain of Leishmania dono-
vani (LV9) and tandem Tomato fluorescent protein expressing LV9
(tdTom.LV9) (Beattie et al., 2010) were maintained by serial passage in
Rag-1/ mice. Amastigotes were isolated from infected spleens (Smelt
et al., 1997), and mice were infected with 3 3 107 L. donovani amastigotes
intravenously (i.v.) via the tail vein in 200 ml of RPMI 1640 (GIBCO). Parasites
were killed via heat treatment at 56C for 15 min, followed by labeling with
PKH26 Red Fluorescent Cell Linker Kit (Sigma). For latex bead experiments,
1 mm Fluoresbrite Polychromatic Red Microbeads (Polysciences) were
washed twice in saline, and 3 3 107 beads per mouse were injected i.v. All
experiments were approved by the University of York Animal Procedures
and Ethics Committee and performed under UK Home Office license (Immu-
nity and Immunopathology of Leishmaniasis Ref # PPL 60/3708).
Intravital Imaging
Mice were anesthetized, and surgery was performed similar to that previously
described (Beattie et al., 2010), except that anesthesia was maintained by
inhalation of 4% isofluorane (Abbott Laboratories). Images were acquired on
an inverted LSM 780 Multiphoton Microscope (Zeiss) maintained at 36C by
a blacked-out environmental chamber (Solent Scientific). Images were ac-
quired with a 403 1.1 water immersion objective and fluorescence excitation
provided by a Chameleon XR Ti:Sapphire Laser (Coherent) tuned to 870 nm.
For 4D analysis, 20–35 mM z stacks were acquired with a z distance of 2 mM
approximately every 15–30 s. Real-time injection was performed via tail vein
catheter (Strategic Applications Incorporated, Infusion Technologies). In addi-
tion to collecting baseline data for animals before infection, individual KCs
were imaged prior to and for 2 hr directly following infection of mice with
L. donovani. Data were rendered and analyzed using Volocity software (Perki-
nElmer), and cell analysis was performed automatically with manual checking.
Confocal Microscopy
Confocal microscopy was performed on 20 mm frozen sections as previously
described (Beattie et al., 2011). Antibodies were conjugated to Alexa 488 or
Alexa 647 (eBioscience). Slides were blinded before imaging on a Zeiss LSM
510 Axioplan Microscope (Zeiss). Data were rendered and analyzed using
Volocity Software (Improvision).
Flow Cytometry and Cell Sorting
Hepatic mononuclear cells were prepared from the livers of tdTom.LV9- or
RPMI-injected C57BL/6 mice. A total of 64 mice were used for the microarray
study. We conducted four independent infection experiments to generate
samples for analysis. In each experiment, n = 16 mice, and at each time point
studied (2 hr and 12 hr postinfection), we isolated KCs from the livers of four
mice treated with RPMI and four mice infected with L. donovani. Liver mono-
nuclear cells were pooled prior to sorting. For real-time PCR analysis, repli-
cates represent pooled samples from independently sorted samples. Livers
were perfused with 0.4 mg/mL of warmed Liberase TL (Roche) then digested
at 37C for 45 min. Digested livers were passed over 100 mM cell strainers,
washed in PBS containing 2% fetal calf serum (FCS), and resuspended in
33% Percoll for centrifugation at 693 3 g for 12 min. Isolated cells were
blocked with anti CD16/32 then labeled with F4/80-Alexa 488, GR-1 PeCy7
(eBioscience), and CRIg (Helmy et al., 2006) that was conjugated to Atto
647H via lightning-link conjugation (Innova Biosciences). Cells were sorted
on a MoFlo Cell Sorter (Beckman Coulter). Sorted cells were pelleted and re-366 Cell Host & Microbe 14, 357–368, September 11, 2013 ª2013 Elsuspended in TRIzol (Invitrogen). A small fraction of cells (approximately 3,000
sorted cells) were spun onto glass slides, fixed in methanol, and stained with
Giemsa for morphological analysis.
Whole-Genome Array
RNA was isolated from purified KC and amplified via Agilent Low Input Quick
Amp Labeling Kit (Agilent Technologies). Amplified RNA was then assayed
with Agilent SurePrint G3 Mouse Gene Expression 8360K Microarray Chips
that were scanned with an Agilent C Scanner with SureScan High-Resolution
Technology (Agilent). The data were normalized using the percentile shift
method to the 80th percentile. Comparison of the gene expression data be-
tween the RPMI controls and the infected or inflamed samples was performed
using the Benjamini and Hochberg false discovery rate (FDR) correction (Pa-
witan et al., 2005a), albeit with the caveat that this approach may have low
sensitivity with the sample size used (Pawitan et al., 2005b). This analysis
was performed with GeneSpring software (version 9; Agilent) as a standard
5% FDR, with the variances assessed by the software for each t test per-
formed. A 3-fold expression criteria was then applied to each gene list. All
data for long intergenic noncoding RNA (lincRNA) probe sets were removed
from the analysis at this point. Gene ontology analysis was performed using
the DAVID (Huang et al., 2009) and Ingenuity Pathway Analysis software pack-
ages (Ingenuity Systems), and gene maps generated with STRING (www.
string-db.org).
Drug Treatment
Mice were pretreated with saline, 100 mg/kg HX531 (Yamauchi et al., 2001),
30 mg/kg LG268 (Shen et al., 2004), or 20 mg/kg GW3965 (Lei et al., 2013)
2–6 hr prior to infection and then every 24 hr until 72 hr for HX531 and
LG268 or every 12 hr for GW3965. At 96 hr postinfection, the livers and spleens
were collected, and the parasite burden was determined both by flow cytom-
etry and in fixed liver slices. Data were normalized to the baseline 2 hr time
point to determine the survival of parasites relative to the initial dose of
infection.
Determination of Parasite Burden by Flow Cytometry
Liver and spleens were collected, homogenized, and resuspended in a spe-
cific volume of RPMI 1640 (GIBCO). A total of 200 ml of each sample was ali-
quoted in duplicate to a 96-well plate, centrifuged at 2,000 3 g for 10 min,
and the pellets were resuspended in 2 mg/mL saponin for 5 min at room tem-
perature (RT). The centrifugation was repeated and followed by resuspension
in 1 mg/mL saponin. The remaining pellets were washed a further two times,
and the wells were resuspended in 200 ml then spiked with 2 ml of 6 mM poly-
styrene microspheres (Polysciences, Inc.) at 4.6 3 105 particles/mL. Samples
were acquired on a CyAn ADP analyzer (Beckman Coulter) in which both for-
ward scatter detector neutral density filters had been removed to allow for
small-particle detection. The number of parasites was quantitated by deter-
mining the ratio of beads to parasites and thenmultiplying to calculate the total
number of parasites in the starting volume.
Real-Time PCR
Isolated cells were resuspended and frozen in QIAzol lysis buffer. RNA was
isolated from sorted cell populations using a miRNeasy Kit (QIAGEN). RNA
was reverse transcribed into complementary DNA (cDNA) with a Superscript
III First-Strand Synthesis Kit (Invitrogen). Oligonucleotides used for the spe-
cific amplification of target genes are described in the Supplemental Experi-
mental Procedures. Real-time quantitative PCR was performed with Fast
SYBR Green PCR Master Mix in a StepOnePlus Real-Time PCR System
(Applied Biosystems). Accumulation of target genes was normalized to
HPRT, b-actin (Shih et al., 2012), or ribosomal protein L32 (Reis et al., 2013)
and expressed as relative expression via the change in cycle threshold
(DDCT) analysis method (relative expression in test sample versus RPMI
controls).
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